10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $164,400,637 | -28.5% | 3,985,470 | -3.3% | 0.56% | -21.6% |
Q2 2023 | $230,075,821 | +10.3% | 4,120,269 | +10.2% | 0.71% | +3.9% |
Q1 2023 | $208,530,077 | +178352.0% | 3,737,768 | +16.6% | 0.69% | +55.8% |
Q4 2022 | $116,855 | -99.9% | 3,206,783 | -5.4% | 0.44% | +21.8% |
Q3 2022 | $96,581,000 | -39.5% | 3,391,177 | -3.8% | 0.36% | -34.4% |
Q2 2022 | $159,591,000 | -34.5% | 3,526,878 | +10.2% | 0.55% | -1.4% |
Q1 2022 | $243,530,000 | -1.7% | 3,201,394 | +92.4% | 0.56% | +21.7% |
Q4 2021 | $247,865,000 | – | 1,663,967 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |